These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Immunohistochemical staining of tumor necrosis factor-α and interleukin-10 in benign and malignant ovarian neoplasms. Jammal MP; DA Silva AA; Filho AM; DE Castro Côbo E; Adad SJ; Murta EF; Nomelini RS Oncol Lett; 2015 Feb; 9(2):979-983. PubMed ID: 25624918 [TBL] [Abstract][Full Text] [Related]
43. Immune Biomarkers in Blood from Sarcoma Patients: A Pilot Study. Munisamy S; Radhakrishnan AK; Ramdas P; Samuel PJ; Singh VA Curr Oncol; 2022 Aug; 29(8):5585-5603. PubMed ID: 36005179 [TBL] [Abstract][Full Text] [Related]
44. Gasotransmitters in the tumor microenvironment: Impacts on cancer chemotherapy (Review). Salihi A; Al-Naqshabandi MA; Khudhur ZO; Housein Z; Hama HA; Abdullah RM; Hussen BM; Alkasalias T Mol Med Rep; 2022 Jul; 26(1):. PubMed ID: 35616143 [TBL] [Abstract][Full Text] [Related]
45. The Potential Role of iNOS in Ovarian Cancer Progression and Chemoresistance. Kielbik M; Szulc-Kielbik I; Klink M Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30970628 [TBL] [Abstract][Full Text] [Related]
46. Significance of TNF-α and the Adhesion Molecules: L-Selectin and VCAM-1 in Papillary Thyroid Carcinoma. Kobawala TP; Trivedi TI; Gajjar KK; Patel DH; Patel GH; Ghosh NR J Thyroid Res; 2016; 2016():8143695. PubMed ID: 26881177 [TBL] [Abstract][Full Text] [Related]
47. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777 [TBL] [Abstract][Full Text] [Related]